OxyContin heirs find buyer for $6.5M Manhattan condo—take a look inside
Embattled pharmaceutical heirs David and Joss Sackler — who came into the public eye after their family company, OxyContin maker Purdue Pharma, was accused of fueling the ongoing U.S. opioid crisis — have found a buyer for their Manhattan mega-condo. The price: $6.5 million.
The average price for a New York City condo, by comparison, was $1.95 million in 2018, according to listings site CityRealty.
It makes sense that the Sacklers' condo beat the average sales price six-fold, though: It’s 3,343 square feet comes with four bedrooms and five bathrooms. It also features a floor-to-ceiling fireplace and a wine cooler in the kitchen. As well, the Upper East Side building has a children’s playroom, concierge, fitness center and rooftop lounge.
It was put on the market in April and handled by Warburg Realty.
OxyContin heirs' Manhattan condo. (Warburg Realty.)
Purdue Pharma filed for Chapter 11 bankruptcy Sunday days after reaching a tentative settlement with many of the state and local governments suing it over the toll of opioids.
Earlier this month, the Trump administration announced $1.8 billion in grants to help fight the opioid epidemic. About 130 Americans die every day from opioid-related drug overdoses, per the Centers for Disease Control and Prevention.
CLICK HERE TO READ MORE ON FOX BUSINESS